Hear the inspiring stories of real people with HER2+ early breast cancer who switched from IV PERJETA (pertuzumab) + Herceptin (trastuzumab) to PHESGO after talking to their doctor.
As a wife, mom, art lover, and nature enthusiast, Jen does it all. Learn about her and about why she made the switch to PHESGO for her HER2+ breast cancer treatment.
Liv is busy working and raising four kids. Learn about her and about how PHESGO's shorter administration time helps her spend more of her time the way she wants to spend it.
The information contained in this section of the site is intended for U.S. healthcare professionals only. Click "OK" if you are a healthcare professional.
The link you have selected will take you away from this site to one that is not owned or controlled by Genentech, Inc. Genentech, Inc. makes no representation as to the accuracy of the information contained on sites we do not own or control. Genentech does not recommend and does not endorse the content on any third-party websites. Your use of third-party websites is at your own risk and subject to the terms and conditions of use for such sites.